CogNet AI-MT+
Breast Cancer Detection (Mammography)
ApprovedActive
Key Facts
About MedCognetics
MedCognetics is a private, commercial-stage AI diagnostics company specializing in oncology, particularly breast cancer detection via mammography. The company has achieved a key regulatory milestone with FDA clearance for its CogNet AI-MT+ software. It employs a global, collaborative approach to data sourcing to build an unbiased AI system, aiming to address radiologist burnout and shortages while improving screening efficiency and early detection rates.
View full company profileTherapeutic Areas
Other Breast Cancer Detection (Mammography) Drugs
| Drug | Company | Phase |
|---|---|---|
| DL Precise™ for Breast Imaging | DeepLook Medical | Approved |